PMC PMC Report Outlines Strong Growth, Future Challenges for Personalized Medicine Industry Premium As adoption of personalized medicines has accelerated over the last four years, so has the number of marketed genetic and exome tests. Wide Variation in Genomic Testing Utilization Across US, Report Finds The report also identified opportunities to improve adoption through dissemination of evidence supporting the clinical and economic utilization of testing. Intermountain Healthcare to Gather Utility Data as SelectHealth Covers PGx Test for Certain Employees Premium SelectHealth will cover PGx testing for Intermountain employees and beneficiaries with major depressive disorder who have failed treatment. Public Awareness of Personalized Medicine Not Growing in Step With Industry, Survey Shows Although people have greater access to personalized drugs and tests than ever before, a survey by GenomeWeb and the PMC shows public awareness isn't improving. Personalized Medicine Continued Growth in 2017 Despite Political, Reimbursement Uncertainty Premium The year brought more FDA approvals for molecularly targeted drugs and NGS tests for personalizing cancer treatment, but reimbursement remained a stress point for industry. Dec 29, 2016 Cures Act Gives Precision Medicine Proponents, Diagnostics Companies Reasons to Celebrate Premium Apr 7, 2016 Warren, Enzi Bill Seeks to Tighten Protections for Genetic Information in Research Premium Mar 18, 2016 Sen. Alexander Introduces Bill to Continue Implementation of Precision Medicine Initiative Feb 4, 2016 FDA to Finalize LDT Guidance Amid Uncertainty on Number of Genetic Tests Impacted Jul 23, 2015 Researchers Develop Decision Matrix to Guide Payors on Clinical, Economic Value of Companion Tests Premium May 20, 2015 Pharma's Personalized Medicine Investment Remains Steady; Science a Major Hurdle, Tufts Report Shows Premium Apr 17, 2015 Small Group of Labs, Dx Manufacturers Float Alternative to FDA LDT Guidance Jan 28, 2015 Draft of 21st Century Cures Legislation Addresses Device Reforms, but Silent on LDTs Jan 12, 2015 Stakeholders Ask FDA to Educate Labs on Agency Thinking, Terminology Before Finalizing LDT Guidance Sep 17, 2014 People in the News: Daryl Pritchard, Grail Sipes, Brian Hansen, Alberto Bardelli, and More Premium Aug 6, 2014 FDA Draft LDT Guidance Slated for Release in 60 Days; Industry Readying Recommendations, Objections Premium Aug 6, 2014 Industry to Seek Details from FDA on Risk Classification, Implementation of LDT Regulatory Framework Premium Jul 22, 2014 Majority of Americans Unaware of Personalized Medicine: Survey Jul 16, 2014 PMC Report Tackles Complex Challenges of Reimbursement, Pricing of MDx Premium Jun 25, 2014 PMC Issues New Report on Personalized Medicine Market Growing in Products, Challenges Premium Apr 2, 2014 Market-based Reimbursement Provisions for Lab Tests in HR 4302 Passes Senate with Industry Backing Premium Dec 18, 2013 People in the News: William Burns, Christoph Franz, Steven Averbuch, Michael Kolodziek Premium Jun 5, 2013 After Long Silence on LDT Regulation, FDA Commish Revives Thorny Topic at ASCO Premium Dec 14, 2012 People In The News: Dec 14, 2012 Jul 25, 2012 PMC Urges Stakeholders to Provide Feedback as PCORI Opens Comment Period for Methodology Report Premium Load More Breaking News Qiagen Gets CE Mark for Therascreen EGFR Plus RGQ Kit for Non-Small Cell Lung Cancer New CRISPR Approach Enables Gene Editing in Cockroaches, Potentially Many Insect Species Delfi Diagnostics, Memorial Sloan Kettering Partner to Advance Cancer Screening Technology Mirvie Raises $60M in Series B Funding Interpace Biosciences Posts 6 Percent Revenue Increase in Q1 Ginkgo Bioworks Q1 Revenues More Than Triple The Scan Booster for Kids The US Food and Drug Administration has authorized a booster dose of Pfizer-BioNTech's SARS-CoV-2 vaccine for 5-to-11-year olds, the Washington Post reports. Novavax Anticipates Authorization Novavax expects to receive US Food and Drug Administration authorization for vaccine soon, according to CNBC. Some Old Microbes Indeed Vice reports that researchers may have uncovered 830-million-year-old microbes. PNAS Papers on Meiotic Crossover, RNA Targeting, SNAT7 mTORC1 Regulation In PNAS this week: meiotic crossover formation in C. elegans, approach to identify small molecules affecting RNA activity, and more.